The Development of Novel Antimalarial Drugs
American Journal Of Pharmacy And Pharmacology · 30.06.2023 · 4 (3) · 1-5
DOI: 10.71465/ajpp.2297 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 30.06.2023. Verfasst von Dr. Samuel Patel.
Abstract (Originalsprache)
Malaria remains one of the most devastating infectious diseases globally, causing millions of deaths annually. Despite advances in prevention and treatment, drug resistance continues to be a major challenge in malaria control. This article reviews the development of novel antimalarial drugs, focusing on new classes of drugs, their mechanisms of action, and their potential for overcoming drug resistance. We explore the latest research on artemisinin-based combination therapies, as well as innovative approaches such as the use of natural products, gene editing, and immune modulation. Additionally, the article highlights the challenges faced in the development of new drugs and the need for continued investment in research and development.
Zitieren
APA
Patel, D. S. (2023). The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology, 4(3), 1-5. https://doi.org/10.71465/ajpp.2297
Vancouver
Patel DS. The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology. 2023;4(3):1-5. doi:10.71465/ajpp.2297
BibTeX
@article{Patel2023,
author = {Patel, Dr. Samuel},
title = {The Development of Novel Antimalarial Drugs},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2023},
volume = {4},
number = {3},
pages = {1--5},
doi = {10.71465/ajpp.2297}
}
EUVIMED